AEMD vs. INBS, LYRA, DHAI, WOK, PAVM, SSKN, NURO, CODX, BTCY, and SINT
Should you be buying Aethlon Medical stock or one of its competitors? The main competitors of Aethlon Medical include Intelligent Bio Solutions (INBS), Lyra Therapeutics (LYRA), DIH Holding US (DHAI), WORK Medical Technology Group (WOK), PAVmed (PAVM), Strata Skin Sciences (SSKN), NeuroMetrix (NURO), Co-Diagnostics (CODX), Biotricity (BTCY), and Sintx Technologies (SINT). These companies are all part of the "medical equipment" industry.
Aethlon Medical vs. Its Competitors
Aethlon Medical (NASDAQ:AEMD) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.
In the previous week, Intelligent Bio Solutions had 2 more articles in the media than Aethlon Medical. MarketBeat recorded 5 mentions for Intelligent Bio Solutions and 3 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 0.93 beat Intelligent Bio Solutions' score of 0.76 indicating that Aethlon Medical is being referred to more favorably in the media.
Aethlon Medical has a beta of 1.69, meaning that its share price is 69% more volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.6, meaning that its share price is 360% more volatile than the S&P 500.
Intelligent Bio Solutions has higher revenue and earnings than Aethlon Medical.
2.0% of Aethlon Medical shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 1.2% of Aethlon Medical shares are owned by company insiders. Comparatively, 1.5% of Intelligent Bio Solutions shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Aethlon Medical currently has a consensus price target of $56.00, suggesting a potential upside of 4,434.41%. Given Aethlon Medical's stronger consensus rating and higher probable upside, equities research analysts plainly believe Aethlon Medical is more favorable than Intelligent Bio Solutions.
Aethlon Medical has a net margin of 0.00% compared to Intelligent Bio Solutions' net margin of -319.85%. Intelligent Bio Solutions' return on equity of -176.55% beat Aethlon Medical's return on equity.
Summary
Intelligent Bio Solutions beats Aethlon Medical on 8 of the 13 factors compared between the two stocks.
Get Aethlon Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding AEMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aethlon Medical Competitors List
Related Companies and Tools
This page (NASDAQ:AEMD) was last updated on 7/17/2025 by MarketBeat.com Staff
Free AEMD Stock Alerts